TERMINATION AND LICENSE AGREEMENTTermination and License Agreement • March 19th, 2014 • Scynexis Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 19th, 2014 Company Industry JurisdictionThis Termination and License Agreement (the “Agreement”) is made and entered into as of May 24, 2013 (the “Effective Date”) by and between Merck Sharp & Dohme Corp., a New Jersey corporation with a principal place of business at One Merck Drive, Whitehouse Station, NJ 08889 (“Merck”) and Scynexis, Inc., a Delaware corporation with a principal place of business at 3501 C Tricenter Boulevard, Durham, NC 27713 (“Scynexis”) (each individually a “Party” and, collectively, the “Parties”).
TERMINATION AND LICENSE AGREEMENTTermination and License Agreement • February 27th, 2014 • Scynexis Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledFebruary 27th, 2014 Company Industry JurisdictionThis Termination and License Agreement (the “Agreement”) is made and entered into as of May 24, 2013 (the “Effective Date”) by and between Merck Sharp & Dohme Corp., a New Jersey corporation with a principal place of business at One Merck Drive, Whitehouse Station, NJ 08889 (“Merck”) and Scynexis, Inc., a Delaware corporation with a principal place of business at 3501 C Tricenter Boulevard, Durham, NC 27713 (“Scynexis”) (each individually a “Party” and, collectively, the “Parties”).